BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28447402)

  • 21. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
    Bodakçi E
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
    Shiboski CH; Baer AN; Shiboski SC; Lam M; Challacombe S; Lanfranchi HE; Schiødt M; Shirlaw P; Srinivasan M; Umehara H; Vivino FB; Akpek E; Bunya V; Vollenweider CF; Greenspan JS; Daniels TE; Criswell LA;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):284-294. PubMed ID: 28437595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and impact of Sjögren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis.
    Deng X; Li J; Hou S; Ci B; Liu B; Xu K
    Ann Hepatol; 2022; 27(6):100746. PubMed ID: 35970319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
    Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
    Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
    Hansen B; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and immunological features of Sjögren's syndrome in patients with primary biliary cirrhosis with emphasis on focal sialadenitis.
    Hansen BU; Lindgren S; Eriksson S; Henricsson V; Larsson A; Manthorpe R; Warfvinge G
    Acta Med Scand; 1988; 224(6):611-9. PubMed ID: 3207072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.
    Everett S; Vishwanath S; Cavero V; Shen L; Suresh L; Malyavantham K; Lincoff-Cohen N; Ambrus JL
    BMC Ophthalmol; 2017 Mar; 17(1):20. PubMed ID: 28270126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
    Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
    Huo AP; Lin KC; Chou CT
    Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
    Turkçapar N; Olmez U; Tutkak H; Duman M
    Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-La positive, anti-Ro negative subset of primary Sjögren's syndrome: anti-La is a reality but is the disease?
    Danda D; Sharma R; Truong D; Koelsch KA; Kurien BT; Bagavant H; Deshmukh U; Kaufman CE; Lewis DM; Stone DU; Radfar L; Rasmussen A; Sivils KL; Scofield RH
    Clin Exp Rheumatol; 2017; 35(3):438-444. PubMed ID: 28229827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.
    Moutsopoulos HM; Zerva LV
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):123-30. PubMed ID: 2203591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
    Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Sjögren's syndrome.
    Bowman SJ
    Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
    Locht H; Pelck R; Manthorpe R
    J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.